-- 
Amgen’s Xgeva Delays Spread of Prostate Cancer to Bone in Study

-- B y   K r i s t e n   H a l l a m
-- 
2011-09-24T22:01:00Z

-- http://www.bloomberg.com/news/2011-09-24/amgen-s-xgeva-delays-spread-of-prostate-cancer-to-bone-in-study.html
Amgen Inc. (AMGN) ’s Xgeva, sold as a
treatment to reduce fractures in cancer patients, delayed the
spread of prostate cancer to the bones in a study involving more
than 1,400 men. The results will be presented today at the
European Multidisciplinary Cancer Congress in  Stockholm .  To contact the reporter on this story:
Kristen Hallam in London at 
 khallam@bloomberg.net   To contact the editor responsible for this story:
Phil Serafino at 
 pserafino@bloomberg.net  